Jagsonpal Pharmaceuticals Market Cap

Jagsonpal Pharmaceuticals has a market cap or net worth of 14.25 billion as of June 18, 2026. Its market cap has decreased by -9.45% in one year.

Market Cap

14.25B

Enterprise Value

13.27B

Revenue

2.87B

Ranking

n/a

PE Ratio

33.64

Stock Price

212.28

Market Cap Chart

Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 14.25B, a decrease of -19.16%. That is a compound annual growth rate of -0.81%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2026	14.25B	10.80%
Dec 31, 2025	12.86B	-20.68%
Dec 31, 2024	16.22B	58.61%
Dec 29, 2023	10.22B	4.69%
Dec 30, 2022	9.77B	108.36%
Dec 31, 2021	4.69B	150.03%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Innova Captab	54.34B
Orchid Pharma	49.66B
RPG Life Sciences	37.67B
Solara Active Pharma Sciences	27.13B
Indoco Remedies	21.69B
Beta Drugs	20.09B
Sakar Healthcare	17.88B
Windlas Biotech	16.84B

Market Cap Rankings